Drug discovery and development for neglected diseases: the DNDi model
Eric Chatelain, Jean-Robert IosetDrugs for Neglected Diseases Initiative (DNDi), Geneva, SwitzerlandAbstract: New models of drug discovery have been developed to overcome the lack of modern and effective drugs for neglected diseases such as human African trypanosomiasis (HAT; sleeping sickness), lei...
Saved in:
Main Authors: | Eric Chatelain (Author), Jean-Robert Ioset (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2011-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Addressing the most neglected diseases through an open research model: The discovery of fenarimols as novel drug candidates for eumycetoma.
by: Wilson Lim, et al.
Published: (2018) -
Film-Forming Systems for the Delivery of DNDI-0690 to Treat Cutaneous Leishmaniasis
by: Katrien Van Bocxlaer, et al.
Published: (2021) -
Innovation in neglected tropical disease drug discovery and development
by: Hong-Bo Weng, et al.
Published: (2018) -
Innovative partnerships for drug discovery against neglected diseases.
by: Palle H Jakobsen, et al.
Published: (2011) -
Finding new collaboration models for enabling neglected tropical disease drug discovery.
by: Michael P Pollastri
Published: (2014)